Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Carrillo

Showing results (111-120 of 243) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseMarilyn S Albert, Steven T DeKosky, Dennis Dickson, et al.
Neurology|July 3, 2016
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersClifford R Jack, David A Bennett, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 8, 2016
Tau: From research to clinical developmentDavid M Holtzman, Maria C Carrillo, James A Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Research and standardization in Alzheimer's trials: reaching international consensusMaria C Carrillo, Christopher C Rowe, Cassandra Szoeke, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2026
Identification of patients receiving amyloid-targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADSRenaud La Joie, Ganna Blazhenets, Piyush Maiti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2011
Revision of the criteria for Alzheimer’s disease: A symposiumSteven T DeKosky, Maria C Carrillo, Creighton Phelps, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB)Enchi Liu, Johan Luthman, Jesse M Cedarbaum, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug developmentGil D Rabinovici, Maria C Carrillo, Mark Forman, et al.
JAMA Neurology|October 3, 2022
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort StudyConsuelo H Wilkins, Charles C Windon, Peggye Dilworth-Anderson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
The roles of inflammation and immune mechanisms in Alzheimer's diseaseLinda J Van Eldik, Maria C Carrillo, Patricia E Cole, et al.
Pageof 25

Showing results (111-120 of 243) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseMarilyn S Albert, Steven T DeKosky, Dennis Dickson, et al.
Neurology|July 3, 2016
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersClifford R Jack, David A Bennett, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 8, 2016
Tau: From research to clinical developmentDavid M Holtzman, Maria C Carrillo, James A Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Research and standardization in Alzheimer's trials: reaching international consensusMaria C Carrillo, Christopher C Rowe, Cassandra Szoeke, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2026
Identification of patients receiving amyloid-targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADSRenaud La Joie, Ganna Blazhenets, Piyush Maiti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2011
Revision of the criteria for Alzheimer’s disease: A symposiumSteven T DeKosky, Maria C Carrillo, Creighton Phelps, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB)Enchi Liu, Johan Luthman, Jesse M Cedarbaum, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug developmentGil D Rabinovici, Maria C Carrillo, Mark Forman, et al.
JAMA Neurology|October 3, 2022
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort StudyConsuelo H Wilkins, Charles C Windon, Peggye Dilworth-Anderson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
The roles of inflammation and immune mechanisms in Alzheimer's diseaseLinda J Van Eldik, Maria C Carrillo, Patricia E Cole, et al.
Pageof 25